justthenews11d
Moderna buried child's death in COVID booster trial in EU report, FDA response called 'misleading'
Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...
MercoPress1d
COVID-19 booster shots are better if specific brands are used
researchers recommended that people who received it get a second booster dose with an mRNA vaccine such as Moderna and Pfizer. According to the published results, there were 129 coronavirus ...
Time7d
A Norovirus Vaccine May Be Coming
There is no antiviral treatment for the miserable but thankfully short-lived illness, and no vaccine—yet. But scientists at Moderna are in the late stages of testing what could be the first such ...
The Boston Globe4d
Moderna shares plunge after company cuts vaccine sales outlook
Moderna Inc. shares plunged after the company slashed its sales forecast for this year as it struggles with slow demand for its Covid and RSV vaccines. The Cambridge, Massachusetts-based company ...
Moderna shares slide as it slashes revenue forecast
Moderna slashed its 2025 revenue projection by $1bn on Monday, citing reduced demand for its Covid-19 and respiratory ...
Wall Street Journal5d
Moderna Stock Plunges After Vaccine Sales Struggle
Shares of Moderna plunged 20% Monday after the vaccine maker slashed its forecast of full-year 2025 revenue, as sales of its vaccines against Covid-19 and respiratory syncytial virus continue to ...
Monthly Prescribing Reference3d
Moderna Provides Update on Norovirus Vaccine Candidate
Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial investigating a ...
Northeast Ohio pediatrician’s office working with Moderna on a potential mono vaccine
The research team at Senders Pediatrics is working with Moderna to study a vaccine developed for Epstein-Barr Virus, which ...